Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robohogs who wrote (1722)	2/19/2002 10:05:07 AM
From: Bob Rudd	Read Replies (2) of 10345

JR Great work. Thanks for posting your valuation. Shouldn't the Break up II reflect debt? 4. Breakup Analysis II Antegren $1 B - $2 B Drug Delivery $2 B - $3 B Drugs ($1.2B Core) $3 B - $6 B Cash/stock $1 B - $1 B Drugs in JVs $1 B - $5 B Total $8 B - $17B Share Value $20+ - $40+ Less: Debt (1,989.0) Off B-S Debt (1,000.0) Total $5 B - $14B Shares 385 $13 - $36 per share

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next